Is Ivermectin safe for dogs and cats?
High risk for petsIvermectin toxicity in dogs is profoundly influenced by ABCB1 (MDR1) gene mutation status. Dogs with the ABCB1-1Δ (MDR1) frameshift mutation — affecting approximately 75% of rough collies, 50% of smooth collies, and significant proportions of Shetland sheepdogs, Australian shepherds, Old English sheepdogs, McNabs, long-haired whippets, Silken Windhounds, and crosses of these breeds — lack functional P-glycoprotein at the blood-brain barrier. In MDR1-mutant dogs, ivermectin crosses freely into the CNS, causing severe neurotoxicity (mydriasis, ataxia, disorientation, tremors, seizures, coma) at standard anti-parasitic doses that are safe for non-mutant dogs. MDR1-wild-type dogs tolerate ivermectin at typical heartworm prevention doses (6 μg/kg monthly) without issue, but toxic signs can occur even in wild-type dogs at the much higher doses used in some livestock formulations if accidentally ingested. Common exposure scenarios for dogs include ingestion of horse feces containing ivermectin residues, licking of large-animal pour-on formulations, or owners unknowingly using ivermectin-containing livestock products on dogs. A DNA test is available to determine MDR1 status. Treatment of toxicosis requires extended supportive care; intravenous lipid emulsion has been used as adjunctive therapy.
What is ivermectin?
Also known as: 22,23-dihydroabamectin, 22,23-dihydroavermectin b1, 22,23-dihydroavermectin b1a, 22,23-dihydro c-076b1.
- CAS number
- 70288-86-7
Risk for dogs
High riskIvermectin toxicity in dogs is profoundly influenced by ABCB1 (MDR1) gene mutation status. Dogs with the ABCB1-1Δ (MDR1) frameshift mutation — affecting approximately 75% of rough collies, 50% of smooth collies, and significant proportions of Shetland sheepdogs, Australian shepherds, Old English sheepdogs, McNabs, long-haired whippets, Silken Windhounds, and crosses of these breeds — lack functional P-glycoprotein at the blood-brain barrier. In MDR1-mutant dogs, ivermectin crosses freely into the CNS, causing severe neurotoxicity (mydriasis, ataxia, disorientation, tremors, seizures, coma) at standard anti-parasitic doses that are safe for non-mutant dogs. MDR1-wild-type dogs tolerate ivermectin at typical heartworm prevention doses (6 μg/kg monthly) without issue, but toxic signs can occur even in wild-type dogs at the much higher doses used in some livestock formulations if accidentally ingested. Common exposure scenarios for dogs include ingestion of horse feces containing ivermectin residues, licking of large-animal pour-on formulations, or owners unknowingly using ivermectin-containing livestock products on dogs. A DNA test is available to determine MDR1 status. Treatment of toxicosis requires extended supportive care; intravenous lipid emulsion has been used as adjunctive therapy.
Risk for cats
Moderate riskCats are generally more sensitive to ivermectin than most dogs, but the drug is used in cats for certain indications (ear mites, cheyletiellosis) at doses below the toxic threshold. Cats lack the MDR1 mutation issue but have lower P-glycoprotein efflux capacity than dogs; neurotoxicity (mydriasis, salivation, ataxia, tremors, coma) occurs at overdose. Accidental exposure scenarios include owners applying dog-label ivermectin products to cats, cats grooming themselves after application of ivermectin-containing dog products, and ingestion of concentrated livestock formulations. Products labeled for dogs sometimes contain pyrethroids in combination with ivermectin — permethrin co-formulation represents an additional extreme feline toxicity risk independent of ivermectin. ASPCA Animal Poison Control Center lists ivermectin as a significant cat toxin. Treatment is supportive; intravenous lipid emulsion has been reported as potentially beneficial in severe cases.
Regulatory consensus
1 regulatory bodyhas classified Ivermectin.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EPA CTX / Skin-Eye | — | Skin Irritation: Category 6.3B (Category 3) (score: moderate) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where pets encounter ivermectin
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Ivermectin:
-
Alternative drug class; Non-pharmacological therapy; Lowest effective dose
Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.Relative cost: 1.2-2×
Frequently asked questions
Is ivermectin safe for pets?
Ivermectin toxicity in dogs is profoundly influenced by ABCB1 (MDR1) gene mutation status. Dogs with the ABCB1-1Δ (MDR1) frameshift mutation — affecting approximately 75% of rough collies, 50% of smooth collies, and significant proportions of Shetland sheepdogs, Australian shepherds, Old English sheepdogs, McNabs, long-haired whippets, Silken Windhounds, and crosses of these breeds — lack functional P-glycoprotein at the blood-brain barrier. In MDR1-mutant dogs, ivermectin crosses freely into the CNS, causing severe neurotoxicity (mydriasis, ataxia, disorientation, tremors, seizures, coma) at standard anti-parasitic doses that are safe for non-mutant dogs. MDR1-wild-type dogs tolerate ivermectin at typical heartworm prevention doses (6 μg/kg monthly) without issue, but toxic signs can occur even in wild-type dogs at the much higher doses used in some livestock formulations if accidentally ingested. Common exposure scenarios for dogs include ingestion of horse feces containing ivermectin residues, licking of large-animal pour-on formulations, or owners unknowingly using ivermectin-containing livestock products on dogs. A DNA test is available to determine MDR1 status. Treatment of toxicosis requires extended supportive care; intravenous lipid emulsion has been used as adjunctive therapy.
What products contain ivermectin?
Ivermectin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
See Ivermectin in the pets app
Look up products containing ivermectin, compare to alternatives, and explore the full data record.
Open in pets View raw API dataSources (4)
- US FDA: Ivermectin — Approved Human Use (Onchocerciasis, Strongyloidiasis), Safety at Therapeutic Doses, Veterinary Concentration Overdose Risk, and COVID-19 Misinformation Advisory (2021) (2021) — regulatory
- WHO: Ivermectin — Macrocyclic Lactone Mechanism, Human Parasitic Disease Applications, Safety Profile, and Population-Level Mass Drug Administration Experience in Onchocerciasis Control Programs (2019) (2019) — regulatory
- ASPCA Animal Poison Control Center: Ivermectin and Macrocyclic Lactone Toxicosis in Dogs and Cats — MDR1/ABCB1 Mutation, Breed-Specific Risk, Clinical Presentation, and Lipid Emulsion Therapy (2022) (2022) — veterinary
- Washington State University Veterinary Clinical Pharmacology Lab: ABCB1 (MDR1) Mutation — Breed Distribution, Drug Sensitivity List Including Ivermectin and Macrocyclic Lactones, and Genetic Testing Recommendations (2023) (2023) — academic
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →